Barclays
TTRX icon

Barclays’s Turn Therapeutics TTRX Stock Holding History

Barclays’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$198K Buy
+13,748
New +$144K ﹤0.01% 3986

Other funds holding TTRX

SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $508M AUM 11.76% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Tamar Securities
Tamar Securities Woodland Hills, California $1.12B AUM 21.31% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
McCarthy Asset Management
McCarthy Asset Management Redwood Shores, California $209M AUM
Cannon Financial Strategists
Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays's TTRX Position: Q3 2026 in Review

Barclays opened a new position in Turn Therapeutics (TTRX) in Q3 2026: 13,748 shares worth $198K. The stake represents ﹤0.01% of the portfolio and ranks #3986 among its holdings.

16 funds tracked by Wall St. Rank hold TTRX as of Q3 2026.

  • Barclays held 13,748 shares of Turn Therapeutics worth $198K as of Q3 2026.
  • Turn Therapeutics was a new Barclays position in Q3 2026.
  • Turn Therapeutics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3986 holding.
  • 16 funds tracked by Wall St. Rank held Turn Therapeutics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.